|
|
News Breaks
|
January 30, 2012
|
| 08:40 EDT |  | VRX, ISTA |
| theflyonthewall.com: | Ista board updates strategic review process | | The Board of Directors of ISTA Pharmaceuticals reiterated its commitment to maximizing shareholder value and said it will continue its previously announced review of all strategic options available to the Company. The Board issued its statement in response to a press release from Valeant Pharmaceuticals International (VRX) announcing that Valeant had withdrawn its unsolicited proposal to acquire ISTA. ISTA's review of its strategic options, which the Company publicly announced on December 16, 2011, is advancing expeditiously and in a manner consistent with the Board's fiduciary responsibilities. ISTA is currently in dialogue with a number of parties that have expressed an interest in pursuing a strategic transaction and remains committed to maximizing shareholder value. :theflyonthewall.com |
|
|
News For ISTA;VRX From The Last 14 Days Check below for free stories on ISTA;VRX the last two weeks.
There is 1 item on the Fly with pertinent information.
Sign up for a free trial to see the rest of the stories you've been missing. |
|
May 24, 2012
|
| 07:59 EDT | | VRX |
|
|
|
|
|
Subscribe for More Information